Research and New Technology Committee | |||
| Session 413 - Technology Roadmap: Pharmaceutical Product Development & Manufacturing I | |||
| The FDA Critical Path Initiative has identified the lack of innovative technology in pharmaceutical product development and manufacture to be a major impediment to reducing time to market as well as cost of drugs. In response to this Initiative, the National Institute for Pharamceutical Technology & Education, a non-for-profit organization, in cooperation with ISPE and the FDA has undertaken development of a Technology Roadmap which identifies specific research needs in these technology domains. In this session two of the main areas of the draft roadmap ( pharmaceutical materials and product development) will be reviewed and feedback sollicited from the ChE research community. | |||
| Chair: | Gintaras V. Reklaitis | ||
| CoChair: | Michael Pikal | ||
| 413a | Technology Roadmap: Context and Drivers for Roadmap Development Prabir K. Basu | ||
| 413b | Technology Roadmap: Pharmaceutical Materials Component Michael Pikal | ||
| Panel Discussion | |||
| 413c | Technology Roadmap: Product Development Component Lee E. Kirsch | ||
| Discussion | |||
See more of Liaison Functions